# Acceptability and Adherence to Different Dosing Regimens of the Multistrain Probiotic Vivomixx® 460 Neo 9 in Adults Receiving Antibiotic Therapy.

> **NCT07380009** · NA · RECRUITING · sponsor: **University of Thessaly** · enrollment: 40 (estimated)

## Conditions studied

- Antibiotic Therapy

## Interventions

- **DIETARY_SUPPLEMENT:** One sachet of the probiotic daily
- **DIETARY_SUPPLEMENT:** Two sachets of the probiotic daily

## Key facts

- **NCT ID:** NCT07380009
- **Lead sponsor:** University of Thessaly
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-12-12
- **Primary completion:** 2026-05-30
- **Final completion:** 2026-05-30
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-02-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07380009

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07380009, "Acceptability and Adherence to Different Dosing Regimens of the Multistrain Probiotic Vivomixx® 460 Neo 9 in Adults Receiving Antibiotic Therapy.". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT07380009. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*